InvestorsObserver is giving Clarus Therapeutics Holdings Inc (CRXT) an Analyst Rating Rank of 69, meaning CRXT is ranked higher by analysts than 69% of stocks. The average price target for CRXT is $13.8 and analyst’s rate the stock as a Strong Buy.
Wall Street analysts are rating CRXT a Strong Buy today. Find out what this means to you and get the rest of the rankings on CRXT!
Why are Analyst Ratings Important?
Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve.
InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.
What's Happening With Clarus Therapeutics Holdings Inc Stock Today?
Clarus Therapeutics Holdings Inc (CRXT) stock is trading at $1.52 as of 10:43 AM on Friday, Jan 14, a drop of -$0.04, or -2.56% from the previous closing price of $1.56. The stock has traded between $1.50 and $1.55 so far today. Volume today is less active than usual. So far 51,021 shares have traded compared to average volume of 639,721 shares.
Click Here to get the full Stock Report for Clarus Therapeutics Holdings Inc stock.